Schedule a Meeting

White Paper

Parkview Health

To improve patient outcomes and increase health equity, Parkview Health has brought Digital Diagnostics’ FDA cleared artificial intelligence system, LumineticsCore™ (formerly IDx-DR), to the point-of-care to improve comprehensive diabetes management through the autonomous detection of diabetic retinopathy (including macular edema).

Clinical - Eye exam

Read this white paper to find out more about Parkview Health and LumineticsCore

  • 3 lab and endo facilities providing LumineticsCore exams at the point-of-care
  • 326 patients tested for diabetic retinopathy eye disease using LumineticsCore in 2021
  • 46% of patients tested positive for diabetic eye disease

View the Parkview Health White Paper

Notice: The content embedded within PDF files on this website ("Content") is provided solely for educational purposes. Digital Diagnostics ("Owner") holds exclusive rights to the Content, including but not limited to copyrights, trademarks, and any other intellectual property rights.

Unable to display PDF file. Download instead.